Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.

Clinical trial NCT06167460 · RECRUITING

Trial details

NCT number: NCT06167460
Sponsor: Gene Solutions
Status: RECRUITING
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IIIC Non-Small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Tyrosine Kinase Inhibitors

Start date: 2023-12-04
Primary completion: 2025-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.